Susquehanna International Group’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $653K | Sell |
100,502
-8,066
| -7% | -$52.4K | ﹤0.01% | 3944 |
|
|
2025
Q1 | $861K | Buy |
108,568
+44,314
| +69% | +$351K | ﹤0.01% | 3577 |
|
|
2024
Q4 | $814K | Sell |
64,254
-407
| -0.6% | -$5.16K | ﹤0.01% | 3310 |
|
|
2024
Q3 | $901K | Sell |
64,661
-26,437
| -29% | -$368K | ﹤0.01% | 2808 |
|
|
2024
Q2 | $1.26M | Buy |
91,098
+16,944
| +23% | +$233K | ﹤0.01% | 2265 |
|
|
2024
Q1 | $1.23M | Buy |
74,154
+26,776
| +57% | +$442K | ﹤0.01% | 2372 |
|
|
2023
Q4 | $692K | Sell |
47,378
-7,358
| -13% | -$107K | ﹤0.01% | 3384 |
|
|
2023
Q3 | $672K | Sell |
54,736
-25,334
| -32% | -$311K | ﹤0.01% | 3025 |
|
|
2023
Q2 | $956K | Sell |
80,070
-21,208
| -21% | -$253K | ﹤0.01% | 2776 |
|
|
2023
Q1 | $1.35M | Buy |
101,278
+80,710
| +392% | +$1.08M | ﹤0.01% | 2465 |
|
|
2022
Q4 | $443K | Sell |
20,568
-28,800
| -58% | -$620K | ﹤0.01% | 3395 |
|
|
2022
Q3 | $989K | Buy |
+49,368
| New | +$989K | ﹤0.01% | 2553 |
|
|
2022
Q2 | – | Sell |
-18,604
| Closed | -$185K | – | 5965 |
|
|
2022
Q1 | $185K | Buy |
+18,604
| New | +$185K | ﹤0.01% | 4873 |
|